These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7796846)

  • 1. FR144420, a novel, slow, nitric oxide-releasing agent.
    Kita Y; Ohkubo K; Hirasawa Y; Katayama Y; Ohno M; Nishino S; Kato M; Yoshida K
    Eur J Pharmacol; 1995 Mar; 275(2):125-30. PubMed ID: 7796846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
    Kita Y; Hirasawa Y; Fukuyama S; Ohkubo K; Kato Y; Takamatsu H; Ohno M; Nishino S; Kato M; Seki J
    J Pharmacol Exp Ther; 1996 Feb; 276(2):421-5. PubMed ID: 8632305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.
    Hirasawa Y; Sugimoto T; Fukuyama S; Kato Y; Takamatu H; Ohno M; Nishino S; Kato M; Maeda K; Seki J; Kita Y
    Eur J Pharmacol; 1996 May; 303(1-2):55-9. PubMed ID: 8804911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
    Kita Y; Hirasawa Y; Maeda K; Nishio M; Yoshida K
    Eur J Pharmacol; 1994 May; 257(1-2):123-30. PubMed ID: 8082692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
    Isono T; Sato N; Yamamoto T; Sawada T; Yamazaki S; Miura S; Furuichi A; Ozaki R; Koibuchi Y; Ohtsuka M
    Eur J Pharmacol; 1994 Aug; 260(2-3):163-8. PubMed ID: 7988640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hemodynamic effects of nitric oxide (NO) donors with different NO-releasing properties in rats.
    Kita Y; Hirasawa Y; Kato Y; Ohkubo K; Ohno M; Nishino S; Kato M; Fukuyama S
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):223-8. PubMed ID: 9269950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of new generation fungal derived nitric oxide donors on rabbit basilar artery.
    Islam MS; Ohkuma H; Kimura M; Suzuki S
    Neurol Med Chir (Tokyo); 2003 Apr; 43(4):175-80; discussion 180. PubMed ID: 12760495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of FK409, a new spontaneous NO releaser.
    Kita Y; Ozaki R; Sakai S; Sugimoto T; Hirasawa Y; Ohtsuka M; Senoh H; Yoshida K; Maeda K
    Br J Pharmacol; 1994 Dec; 113(4):1137-40. PubMed ID: 7889266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.
    Fukuyama S; Hirasawa Y; Kato Y; Nishio M; Ohno M; Nishino S; Maeda K; Kato M; Kita Y
    J Pharmacol Exp Ther; 1997 Jul; 282(1):236-42. PubMed ID: 9223559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close correlation between nitric oxide (NO) formation from NO releasers and the biological activities of these agents in rats.
    Kita Y; Fukuyama S; Hirasawa Y
    Jpn J Pharmacol; 1995 Sep; 69(1):69-74. PubMed ID: 8847834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet activities of FK409, a new spontaneous NO releaser.
    Kita Y; Hirasawa Y; Yoshida K; Maeda K
    Br J Pharmacol; 1994 Oct; 113(2):385-8. PubMed ID: 7834188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia.
    Isono T; Sato N; Koibuchi Y; Sakai S; Yamamoto T; Ozaki R; Mori J; Kohsaka M; Ohtsuka M
    Jpn J Pharmacol; 1993 Jul; 62(3):315-24. PubMed ID: 8411778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant mechanism of the new vasodilator, FK409.
    Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
    Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamic and excretory responses in anesthetized rats to FK409, a novel nitric oxide donor.
    Urabe K; Matsumura Y; Nishiura M; Maeda K; Morimoto S
    Eur J Pharmacol; 1997 Feb; 321(2):195-200. PubMed ID: 9063688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
    Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y
    Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
    Hirasawa Y; Nishio M; Maeda K; Yoshida K; Kita Y
    Eur J Pharmacol; 1995 Jan; 272(1):39-43. PubMed ID: 7713147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats.
    Wanstall JC; Kaye JA; Gambino A
    Br J Pharmacol; 1997 May; 121(2):280-6. PubMed ID: 9154338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty.
    Seki J; Nishio M; Kato Y; Motoyama Y; Yoshida K
    Atherosclerosis; 1995 Sep; 117(1):97-106. PubMed ID: 8546759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic treatment with the spontaneous nitric oxide releaser FK409 on vascular responses in established streptozotocin-induced diabetic rat.
    Kamata K; Hayashi T
    Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):275-94. PubMed ID: 10509739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.
    Matsumura Y; Nishiura M; Deguchi S; Hashimoto N; Ogawa T; Seo R
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1084-91. PubMed ID: 9864296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.